Xali Gold Corp. (XGC.V)
CAD 0.05
(0.0%)
CAD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -195.45 Thousand | -21.58 Thousand | -265.97 Thousand | -78.89 Thousand | -53.88 Thousand | -192.19 Thousand |
| Net Income | -942.78 Thousand | -1.52 Million | -1.29 Million | -1.09 Million | -293.7 Thousand | -8.34 Million |
| Depreciation & Amortization | - | - | 274.00 | 326.00 | 1558.00 | 1020.00 |
| Deferred income taxes | - | - | - | - | -44.24 Thousand | 7.94 Million |
| Stock-based compensation | 7872.00 | 33.38 Thousand | 81.8 Thousand | 59.79 Thousand | 5075.00 | 31.18 Thousand |
| Change in working capital | 740.4 Thousand | 1.18 Million | 530.73 Thousand | 856.75 Thousand | 346.42 Thousand | 197.31 Thousand |
| Other non-cash items | 8977.00 | 290.97 Thousand | 416.49 Thousand | 96.21 Thousand | -69 Thousand | -27.96 Thousand |
| Investing Cash Flow | 175 Thousand | -13.26 Thousand | -127.75 Thousand | -44.45 Thousand | -3803.00 | 220.46 Thousand |
| Investments in PPE | - | -13.26 Thousand | -70.25 Thousand | -6760.00 | -2592.00 | -2300.00 |
| Acquisitions | - | - | - | -5000.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 175 Thousand | - | -57.49 Thousand | -32.69 Thousand | -1211.00 | 222.76 Thousand |
| Financing Cash Flow | -239.00 | 38.36 Thousand | 394.57 Thousand | 149.25 Thousand | - | - |
| Debt repayment | -239.00 | -38.9 Thousand | -60.74 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 279.22 Thousand | 152.88 Thousand | - | - |
| Other Financing Activities | -239.00 | 38.36 Thousand | 115.35 Thousand | -3626.00 | - | - |
| Accounts receivables | 2013.00 | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 738.39 Thousand | - | - | - | - | - |
| Cash at beginning of period | 37.02 Thousand | 33.52 Thousand | 32.67 Thousand | 6767.00 | 64.45 Thousand | 36.24 Thousand |
| Cash at end of period | 16.33 Thousand | 37.02 Thousand | 33.52 Thousand | 32.67 Thousand | 6767.00 | 64.45 Thousand |
| Capital Expenditure | - | -13.26 Thousand | -70.25 Thousand | -6760.00 | -2592.00 | -2300.00 |
| Effect of forex changes on cash | - | - | - | - | - | -66.00 |
| Net cash flow / Change in cash | -20.69 Thousand | 3504.00 | 851.00 | 25.9 Thousand | -57.68 Thousand | 28.2 Thousand |
| Free Cash Flow | -195.45 Thousand | -34.85 Thousand | -336.22 Thousand | -85.65 Thousand | -56.47 Thousand | -194.49 Thousand |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 232.41 Thousand | -942.78 Thousand | -543.3 Thousand | -198.53 Thousand | -33.99 Thousand | -166.94 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 203.00 | 7872.00 | 986.00 | 1280.00 | 2507.00 | 3099.00 |
| Change in working capital | -4570.00 | 740.4 Thousand | 303.52 Thousand | 155.12 Thousand | 61.31 Thousand | 220.44 Thousand |
| Other non-cash items | 107.09 Thousand | 8977.00 | -4121.00 | 38.94 Thousand | -41.55 Thousand | -68.76 Thousand |
| Investing Cash Flow | - | 175 Thousand | 100 Thousand | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 175 Thousand | 100 Thousand | - | - | - |
| Financing Cash Flow | 4749.00 | -239.00 | -4380.00 | 82.00 | 282.00 | 3777.00 |
| Debt repayment | -4749.00 | -239.00 | -4380.00 | -82.00 | -282.00 | -3777.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 4749.00 | - | - | - | - | - |
| Accounts receivables | 6035.00 | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -146.00 | - | - | - | - | - |
| Cash at beginning of period | 16.29 Thousand | 37.02 Thousand | 89.08 Thousand | 17.19 Thousand | 28.63 Thousand | 37.02 Thousand |
| Cash at end of period | 4972.00 | 16.33 Thousand | 16.33 Thousand | 89.08 Thousand | 17.19 Thousand | 28.63 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -11.32 Thousand | -20.69 Thousand | -72.75 Thousand | 71.88 Thousand | -11.44 Thousand | -8388.00 |
| Free Cash Flow | -16.07 Thousand | -195.45 Thousand | -168.37 Thousand | -3192.00 | -11.72 Thousand | -12.16 Thousand |
NATHBIOGEN
SYTIXSE
SAP
000995
WEGZY
GPGC